| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY, USA
* To whom correspondence should be addressed. E-mail: s0tyag01{at}louisville.edu.
Background/objectives: We examined the hypothesis that oxidants generated nitroso-derivatives, activated latent matrix metalloproteinase (MMP), and induced proteinase-activated receptor-1 (PAR-1), leading to disconnection between the endothelium and myocytes. Administration of cardiospecific tissue inhibitor of metalloproteinase-4 (TIMP-4/CIMP) ameliorated the oxidative-proteolytic stress and endothelial-myocyte uncoupling in chronic heart failure (CHF) in mice. Methods: Aortic-venacava-fistula (AVF) was created in 30 male mice (C57BL/6J) and studied at 0, 2 and 8 wks AVF. To reverse cardiac remodeling, as measured by MMP activation, purified CIMP was administered by osmotic mini-pump subcutaneously after 8 wks AVF, and groups of mice (n=6 in each group) were examined after 12 and 16 wks. Results: Levels of PAR-1 in the left ventricle (LV) were increased at 2 and 8 wks (compared to 0 wk no CIMP treatment) but were normal at 12 and 16 wks after CIMP treatment, measured by Western blot. Similar results were obtained for the LV levels of nitrotyrosine, MMP-2, -9 activities, TIMP-1 and -3. However, the levels of TIMP-4, endothelial cell density; responses of cardiac rings to acetylcholine (ACH), and bradykinin (BK) were attenuated at 2 and 8 wks and normalized after CIMP administration in AVF mice. CIMP induced nitric oxide in microvascular endocardial endothelial cells. Conclusions: The results suggest that nitro-generation activated MMP and PAR-1, leading to endothelial-myocyte uncoupling. CIMP treatment normalized PAR-1 expression and ameliorated endothelial-myocyte uncoupling by decreasing oxidant-mediated proteolytic stress in chronic heart failure.
This article has been cited by other articles:
|
|
 |
|
  R. Pawlinski, M. Tencati, C. R. Hampton, T. Shishido, T. A. Bullard, L. M. Casey, P. Andrade-Gordon, M. Kotzsch, D. Spring, T. Luther, et al. Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and Hypertrophy Circulation, November 13, 2007; 116(20): 2298 - 2306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Henderson, N. Tyagi, A. Ovechkin, G. K. Kartha, K. S. Moshal, and S. C. Tyagi Oxidative remodeling in pressure overload induced chronic heart failure Eur J Heart Fail, May 1, 2007; 9(5): 450 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Ovechkin, N. Tyagi, U. Sen, D. Lominadze, M. M. Steed, K. S. Moshal, and S. C. Tyagi 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L905 - L911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Rodriguez, I. G. Joshua, J. C. Falcone, and S. C. Tyagi Pioglitazone prevents cardiac remodeling in high-fat, high-calorie-induced Type 2 diabetes mellitus Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H81 - H87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Ovechkin, N. Tyagi, W. E. Rodriguez, M. R. Hayden, K. S. Moshal, and S. C. Tyagi Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice J Appl Physiol, December 1, 2005; 99(6): 2398 - 2405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tyagi, K. C. Sedoris, M. Steed, A. V. Ovechkin, K. S. Moshal, and S. C. Tyagi Mechanisms of homocysteine-induced oxidative stress Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2649 - H2656. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
